"Why am I so passionate about making patients a No. 1 priority? In part, it’s because at an early age I had an experience as a patient myself that made a big impression on me."

The European Society of Medical Oncology (ESMO) annual congress convened earlier this month in Paris, where, Illumina presented key abstracts demonstrating the clinical utility of comprehensive genomic profiling (CGP). CGP is a next-generation…

As the oncology community gathers for the ESMO Congress in Paris, we sat down with Javier to learn why scientific exchange and the gathering of researchers is so necessary, both for people living with cancer and for those who work in the field.

UnitedHealthcare, part of UnitedHealth Group, and Peloton Interactive, Inc. have renewed and expanded their relationship to help more people get or stay active and improve their overall well-being.

September is National Recovery Month. Together we can reduce stigma, increase awareness of substance use disorder and celebrate the journey of recovery.

At Bristol Myers Squibb, Global Patient Week stands as a pinnacle of our year-round vision to transform patients’ lives through science, bringing together our more than 32,000 employees around the world to celebrate the individuals we work each day…

A conversation with Craig Hopkinson

Wildfire records now seem to be broken every year. According to the National Interagency Fire Center (NIFC), 48,331 fires have burned over 6 million acres across the United States, with 46 active wildfires continuing to burn as of September 1, 2022.

Quest Diagnostic announced that it has received emergency use authorization from the U.S. Food and Drug Administration for the company's lab-developed molecular diagnostic test to aid in the diagnosis of infection with the Monkeypox virus.

Medtronic sales manager Joe Lontai is helping improve how Vietnam’s healthcare systems treat patients during natural disasters.

“For me, meeting my peers, women who were living with HIV and who also had children – that was a turning point for me,” Angelina says. “I needed that kind of support. It really helped me to cope back then.”

Illumina, Inc. today announced that it has invested in six genomics startups for the fifth global funding cycle of Illumina Accelerator in the San Francisco Bay Area and Cambridge, UK.

Anyone can develop AUD, however, certain factors like biology and environment may contribute to a person's predisposition.

One in 3 people living with a disability in Europe suffer from gum disease due to struggles with their oral care routine. That’s why our Oral-B Europe team is leading an effort to make oral care more accessible and positive for all.

The idea of using one drug to treat many diseases is not entirely new. Historically, therapeutics like immunosuppressants or steroids have been used broadly across many immune-mediated diseases.

Ahead of the Global Fund Seventh Replenishment for 2024-2026, the innovative biopharmaceutical industry reaffirms its longstanding commitment to support the Global Fund mission to defeat HIV, TB, and malaria.

It's inevitable: Thanks to technology, we are going to see true breakthroughs in finding powerful medicines, and in treating, diagnosing and, hopefully, curing diseases.

All of our mental health stories, whether they play out on the big screen courtesy of a Hollywood film or are discussed within a small circle of our loved ones, are equally important and deserve to be told.

The Christian Community Health Center (CCHC) recently hosted a Health and Fun Fair in Chicago.

Illumina, a global leader in DNA sequencing and array-based technologies, announced the release of the full agenda for its inaugural Illumina Genomics Forum.

Jay and Sandra Aldrich experienced chronic pain for different reasons, but found relief in the same Medtronic therapy.

The Quest Diagnostics Quest for Health Equity team sponsored a summer intern program to help Scholars from the AMA’s HBCU, HSI, and the Bluford Healthcare Leadership Institute programs gain real-world experience in health equity.

At the 34th European Congress of Pathology (ECP) in Basel, Switzerland, September 3 to 7, 2022, pathologists from more than 100 countries will convene to share and gain insights on advancements in their field.

Predominantly Black and Hispanic lower-income communities are experiencing some of the most devastating impacts of the pandemic. Upon the launch of Q4HE, these vulnerable communities were the first priority.

Illumina a global leader in DNA sequencing and array-based technologies, announced the upcoming presentation of multiple oncology research abstracts at this year’s European Society of Medical Oncology (ESMO) annual meeting, September 9–13 in Paris.